等待开盘 03-27 09:30:00 美东时间
0.000
0.00%
Senti Biosciences granted stock options to eight new employees, totaling 102,500 shares at $3.03 per share, under its 2022 Inducement Equity Plan. The company focuses on developing next-generation cell and gene therapies using its Gene Circuit platform to treat incurable diseases.
2025-06-09 20:30
Senti Biosciences will host a virtual fireside chat with company executives and Chardan analyst Geulah Livshits, PhD, on June 9, 2025 at 3:00 PM ET. The discussion will focus on the company's next-generation cell and gene therapies using its proprietary Gene Circuit platform.
2025-06-06 13:05